Ann Arbor, MI, United States of America

Jianyong Chen

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 49(Granted Patents)


Location History:

  • Jiangsu, CN (2022)
  • Suzhou, CN (2022)
  • Ann Arbor, MI (US) (2009 - 2023)

Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Jianyong Chen: A Pioneer in Cancer Therapeutics

Introduction

Jianyong Chen is an innovative inventor based in Ann Arbor, MI, known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 15 patents, his work primarily focuses on developing novel compounds aimed at targeting cancer treatments.

Latest Patents

Among his latest innovations are two notable patents:

1. **N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors** - This patent discloses compounds that exhibit potential as therapeutic agents for treating cancer by inhibiting the Bcl-2 protein, which plays a critical role in regulating cell death.

2. **Macrocyclic spiroethers as Mcl-1 inhibitors** - This patent introduces compounds designed to inhibit Mcl-1, another protein involved in cancer progression, furthering the potential for targeted cancer therapies.

Career Highlights

Jianyong Chen has had a distinguished career, working with prestigious institutions such as the University of Michigan, where he conducted groundbreaking research. Additionally, he has collaborated with Ascentage Pharma (Suzhou) Co., Ltd., a company that focuses on developing innovative cancer therapies.

Collaborations

Throughout his career, Chen has worked alongside esteemed colleagues, including Shaomeng Wang and Chao-Yie Yang. These collaborations have enriched his research endeavors and contributed to the development of his patented compounds.

Conclusion

Jianyong Chen stands out in the realm of cancer research, showcasing a dedication to innovation through his patented compounds. His work not only advances the scientific community's understanding of cancer treatment but also holds promise for improving patient outcomes in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…